Literature DB >> 9393355

Malarone-donation programme in Africa.

P B Bloland1, P N Kazembe, W M Watkins, O K Doumbo, O C Nwanyanwu, T K Ruebush.   

Abstract

Entities:  

Keywords:  Africa; Americas; Asia; Critique; Developing Countries; Drugs--therapeutic use; Economic Factors; Financial Activities; Foreign Aid; Organization And Administration; Program Development; Programs; South America; Southeastern Asia; Treatment

Mesh：

Substances：

Year:  1997        PMID： 9393355     DOI： 10.1016/s0140-6736(97)06082-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.

Authors:  Gilles Cottrell; Lise Musset; Véronique Hubert; Jacques Le Bras; Jérôme Clain
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 3.  Atovaquone-proguanil for treating uncomplicated malaria.

Authors:  A Osei-Akoto; L Orton; S P O Owusu-Ofori
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

4.  Biguanide-atovaquone synergy against Plasmodium falciparum in vitro.

Authors:  K Jones; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 5.  Anti-malarial medicine quality field studies and surveys: a systematic review of screening technologies used and reporting of findings.

Authors:  Mirza Lalani; Freddy Eric Kitutu; Siân E Clarke; Harparkash Kaur
Journal:  Malar J       Date:  2017-05-15       Impact factor: 2.979
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.